Deadline approaching: berger montague advises spectrum pharmaceuticals, inc. (nasdaq: sppi) investors to inquire about a securities fraud class action by september 24, 2025

Philadelphia , sept. 12, 2025 /prnewswire/ -- national plaintiffs' law firm berger montague pc  is investigating securities fraud claims against spectrum pharmaceuticals, inc. (nasdaq: sppi) ("spectrum" or the "company") on behalf of investors who purchased or otherwise acquired common shares of spectrum between  march 17, 2022 through september 22, 2022 (the "class period").
ASRT Ratings Summary
ASRT Quant Ranking